Log In
Print this Print this

Kv1.3 blocker

Also known as: BNC245

  Manage Alerts
Collapse Summary General Information
Company Bionomics Ltd.
DescriptionLow molecular weight compound
Molecular Target Potassium channel
Mechanism of ActionK channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
PartnerMerck KGaA

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today